Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Operating Profit (Excl OI) ₹1,635 Cr₹2,320 Cr₹2,084 Cr₹1,698 Cr₹1,586 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,635 Cr based on Mar2024 Consolidated results.
Year Operating Profit
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr
Mar2021₹1,698 Cr
Mar2020₹1,586 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr
22.75
Mar2021 ₹1,698 Cr
7.08
Mar2020 ₹1,586 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,198.9 Cr 0.5% 22.9% 49.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,541.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr 2.1% 1.2% -5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.5%

22.9%

49.7%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses